It has been announced by IBM Watson Health and Teva Pharmaceutical Industries Ltd. that Teva has been chosen as its first Foundational Life Sciences Partner for the Watson Health Cloud. With this, Teva will be the first global pharmaceutical company to use the power of the Watson Health Cloud to help patients and healthcare providers across the world.
Teva has selected the IBM Watson Health Cloud as a preferred cognitive computing platform and is looking forward to come up with solutions to help millions of individuals in the world with complex and chronic health conditions like pain, asthma, migraine and neurodegenerative diseases. Additionally, a joint Teva-IBM Research team will be setting up Big Data and machine learning technology in order to come up with disease models and new therapeutic solutions.
Sourced through Scoop.it from: uncovermichigan.com